Equity

IBB

iShares Biotechnology ETF

Overview

Loading

Performance

Performance

Growth of Hypothetical $10,000

View full chart

Distributions

Record Date Ex-Date Payable Date
View full table

Premium/Discount

  1y 3y 5y 10y Incept.
28.03 8.99 2.47 4.37 6.92
Market Price (%)

as of Dec 31, 2025

27.98 9.03 2.46 4.37 6.92
Benchmark (%)

as of Dec 31, 2025

28.46 9.35 2.83 4.72 -
After Tax Pre-Liq. (%)

as of Dec 31, 2025

27.95 8.92 2.41 4.31 6.88
After Tax Post-Liq. (%)

as of Dec 31, 2025

16.64 6.98 1.89 3.46 5.99
  YTD 1m 3m 6m 1y 3y 5y 10y Incept.
28.03 -2.70 17.05 33.59 28.03 29.48 12.98 53.36 429.44
Market Price (%)

as of Dec 31, 2025

27.98 -2.81 17.03 33.63 27.98 29.60 12.92 53.33 429.37
Benchmark (%)

as of Dec 31, 2025

28.46 -2.66 17.18 33.82 28.46 30.75 14.96 58.53 -
After Tax Pre-Liq. (%)

as of Dec 31, 2025

27.95 -2.72 17.01 33.53 27.95 29.23 12.62 52.45 424.73
After Tax Post-Liq. (%)

as of Dec 31, 2025

16.64 -1.58 10.11 19.92 16.64 22.42 9.84 40.46 325.73
  2021 2022 2023 2024 2025
Total Return (%) 0.99 -13.59 3.62 -2.40 28.03
Market Price (%) 0.95 -13.69 3.76 -2.41 27.98
Benchmark (%) 1.37 -13.27 3.98 -2.11 28.46
The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance quoted.

Key Facts

Key Facts

Net Assets of Fund
as of Jan 07, 2026
$8,711,714,010
Exchange
NASDAQ
Benchmark Index
NYSE Biotechnology Index
Shares Outstanding
as of Jan 07, 2026
49,300,000
Premium/Discount
as of Jan 06, 2026
0.01%
Closing Price
as of Jan 06, 2026
171.24
30 Day Median Bid/Ask Spread
as of Jan 06, 2026
0.03%
Fund Launch Date
Feb 05, 2001
Asset Class
Equity
Bloomberg Index Ticker
ICEBIOT
Distribution Frequency
Quarterly
CUSIP
464287556
30 Day Avg. Volume
as of Jan 07, 2026
1,619,704.00
Daily Volume
as of Jan 06, 2026
1,644,270.00

Portfolio Characteristics

Portfolio Characteristics

Number of Holdings
as of Jan 06, 2026
262
30 Day SEC Yield
as of Nov 30, 2025
0.00%
Standard Deviation (3y)
as of Nov 30, 2025
17.60%
P/B Ratio
as of Jan 06, 2026
4.90
Equity Beta (3y)
as of Nov 30, 2025
0.87
12m Trailing Yield
as of Nov 30, 2025
0.15%
P/E Ratio
as of Jan 06, 2026
30.95
This information must be preceded or accompanied by a current prospectus. For standardized performance, please see the Performance section above.

Fees

Fees

as of current prospectus
Management Fee 0.44%
Acquired Fund Fees and Expenses 0.00%
Other Expenses 0.00%
Expense Ratio 0.44%

The amounts shown above are as of the current prospectus, but may not include extraordinary expenses incurred by the Fund over the past fiscal year. Amounts are rounded to the nearest basis point, which in some cases may be "0.00".

Ratings

Ratings

Morningstar Medalist Rating

Morningstar Medalist Rating - BRONZE
Morningstar has awarded the Fund a Bronze medal. (Effective Nov 30, 2025)
Analyst-Driven % as of Nov 30, 2025
20.00
Data Coverage % as of Nov 30, 2025
100.00

Holdings

Holdings

Ticker Name Sector Asset Class Market Value Weight (%) Notional Value Shares CUSIP ISIN SEDOL Price Location Exchange Currency FX Rate Accrual Date
Holdings are subject to change.


The values shown for “market value,” “weight,” and “notional value” (the “calculated values”) are based off of a price provided by a third-party pricing vendor for the portfolio holding and do not reflect the impact of systematic fair valuation (“the vendor price”). The vendor price is not necessarily the price at which the Fund values the portfolio holding for the purposes of determining its net asset value (the “valuation price”). Holdings data shown reflects the investment book of record, which may differ from the accounting book of record used for the purposes of determining the Net Assets of the Fund. Notional value represents the portfolio's exposures based on the economic value of investments and options are delta-adjusted. Additionally, where applicable, foreign currency exchange rates with respect to the portfolio holdings denominated in non-U.S. currencies for the valuation price will be generally determined as of the close of business on the New York Stock Exchange, whereas for the vendor price will be generally determined as of 4 p.m. London. The calculated values may have been different if the valuation price were to have been used to calculate such values. The vendor price is as of the most recent date for which a price is available and may not necessarily be as of the date shown above.

Please see the “Determination of Net Asset Value” section of each Fund’s prospectus for additional information on the Fund’s valuation policies and procedures.

“Quantity” represents the number of shares, units or contracts of the corresponding security, as applicable per security type.

Exposure Breakdowns

Exposure Breakdowns

as of Jan 06, 2026

% of Market Value

Type Fund
Allocations are subject to change.

This fund does not seek to follow a sustainable, impact or ESG investment strategy. For more information regarding the fund's investment strategy, please see the fund's prospectus or, as applicable, shareholder report.

Literature

Literature